No Data
No Data
Express News | Pharma Two B To Go Public Through Merger With Hepion Pharmaceuticals; Co. Also Announces $2.9M Private Placement Of Non-Convertible Senior Notes To Institutional Investors
Hepion Pharmaceuticals' Shares Fall After Merger Deal With Pharma Two B
Hepion Pharmaceuticals (HEPA) shares fell nearly 19% in recent Monday trading after the company said that it entered a merger deal with Pharma Two B, a private drug development company.Per the
Hepion Pharmaceuticals' Strategic Merger and Corporate Restructuring
Express News | Hepion Pharmaceuticals Shares Are Trading Higher After the Company Announced It Entered Into a Definitive Merger Agreement With Pharma Two B. The Company Announced a $2.9 Million Private Placement of Non-convertible Senior Notes to Institutional Investors
Market-Moving News for July 22nd
RR: 100% | Richtech Robotics Celebrates Completion of Installation of ADAM at Ghost Kitchens inside Dawsonville, GA WalmartMIRA: 84% | MIRA Pharmaceuticals Announces New Preclinical Study Results
Hepion Pharmaceuticals: Pharma Two B Will Apply to List Its Ordinary Shrs on Nasdaq Under Ticker Symbol "PHTB" >HEPA
Hepion Pharmaceuticals: Pharma Two B Will Apply to List Its Ordinary Shrs on Nasdaq Under Ticker Symbol "PHTB" >
No Data